Pilot: Salivary lactoferrin as a potential preclinical Alzheimer's disease biomarker. - Hammerschlag BL; Butts B; Likos KD; Verble DD; Nimmagadda N; Wharton W (Journal of Alzheimer's disease reports, 2025)